Chan, Ya-Ning https://orcid.org/0000-0002-7045-2892
Cho, Youngmin https://orcid.org/0000-0001-7829-8634
Hirschey, Rachel https://orcid.org/0000-0001-8358-0650
Piepmeier, Aaron https://orcid.org/0000-0001-5813-0260
Bender, Catherine M.
Anderson, Ruth A.
Foster, Matthew C.
Bryant, Ashley Leak https://orcid.org/0000-0003-1178-1781
Funding for this research was provided by:
American Cancer Society (134332-DSCN-20-076-01-SCN)
School of Nursing, University of North Carolina at Chapel Hill, United States (Arthur C. Maimon Doctoral Student Research Award (2020-2021))
Alpha Alpha Chapter, Sigma Theta Tau International Honor Society of Nursing (Research Grant)
National Institute on Minority Health and Health Disparities (K23 MD015719-01)
National Institute of Nursing Research (R34NR019131)
Article History
Received: 18 January 2024
Accepted: 20 June 2024
First Online: 3 July 2024
Declarations
:
: Ethical approval was received from the University of North Carolina at Chapel Hill Institutional Review Board (IRB #20–2614) prior to study initiation and the study was conducted in accordance with the Declaration of Helsinki.
: Written informed consent was obtained from all individual participants included in the study.
: During the manuscript preparation and submission, Ya-Ning Chan is a MaRS fellow at Duke University and is funded by GlaxoSmithKline. All other authors declare no competing interests.